198 related articles for article (PubMed ID: 11001911)
21. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse.
Harbott J; Viehmann S; Borkhardt A; Henze G; Lampert F
Blood; 1997 Dec; 90(12):4933-7. PubMed ID: 9389711
[TBL] [Abstract][Full Text] [Related]
22. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study.
Ma SK; Wan TS; Cheuk AT; Fung LF; Chan GC; Chan SY; Ha SY; Chan LC
Leukemia; 2001 Sep; 15(9):1442-7. PubMed ID: 11516105
[TBL] [Abstract][Full Text] [Related]
23. TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia.
Zuna J; Ford AM; Peham M; Patel N; Saha V; Eckert C; Köchling J; Panzer-Grümayer R; Trka J; Greaves M
Clin Cancer Res; 2004 Aug; 10(16):5355-60. PubMed ID: 15328172
[TBL] [Abstract][Full Text] [Related]
24. Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value.
Codrington R; O'Connor HE; Jalali GR; Carrara P; Papaioannou M; Hart SM; Hoffbrand AV; Potter M; Prentice HG; Harrison CJ; Foroni L
Br J Haematol; 2000 Dec; 111(4):1071-9. PubMed ID: 11167742
[TBL] [Abstract][Full Text] [Related]
25. Low frequency of TEL/AML1 in adult acute lymphoblastic leukemia.
Kwong YL; Wong KF
Cancer Genet Cytogenet; 1997 Oct; 98(2):137-8. PubMed ID: 9332479
[TBL] [Abstract][Full Text] [Related]
26. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
[TBL] [Abstract][Full Text] [Related]
27. The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL).
Lee DS; Kim YR; Cho HK; Lee CK; Lee JH; Cho HI
Cancer Genet Cytogenet; 2005 Oct; 162(2):176-8. PubMed ID: 16213368
[TBL] [Abstract][Full Text] [Related]
28. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.
de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743
[TBL] [Abstract][Full Text] [Related]
29. Analysis of TEL proteins in human leukemias.
Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
[TBL] [Abstract][Full Text] [Related]
30. TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL.
Morrow M; Samanta A; Kioussis D; Brady HJ; Williams O
Oncogene; 2007 Jun; 26(30):4404-14. PubMed ID: 17237815
[TBL] [Abstract][Full Text] [Related]
31. AML1 gene over-expression in childhood acute lymphoblastic leukemia.
Mikhail FM; Serry KA; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Coignet L; Nucifora G
Leukemia; 2002 Apr; 16(4):658-68. PubMed ID: 11960347
[TBL] [Abstract][Full Text] [Related]
32. Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes.
Ford AM; Fasching K; Panzer-Grümayer ER; Koenig M; Haas OA; Greaves MF
Blood; 2001 Aug; 98(3):558-64. PubMed ID: 11468150
[TBL] [Abstract][Full Text] [Related]
33. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
[TBL] [Abstract][Full Text] [Related]
34. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
Ramakers-van Woerden NL; Pieters R; Loonen AH; Hubeek I; van Drunen E; Beverloo HB; Slater RM; Harbott J; Seyfarth J; van Wering ER; Hählen K; Schmiegelow K; Janka-Schaub GE; Veerman AJ
Blood; 2000 Aug; 96(3):1094-9. PubMed ID: 10910927
[TBL] [Abstract][Full Text] [Related]
35. The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome.
Lanza C; Volpe G; Basso G; Gottardi E; Perfetto F; Cilli V; Spinelli M; Ricotti E; Guerrasio A; Madon E; Saglio G
Leukemia; 1997 Jun; 11(6):820-1. PubMed ID: 9177434
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of transcriptional repression by TEL/RUNX1 fusion protein.
Lee YJ; Kim JH; Bae S; Rho SK; Choe SY
Mol Cells; 2004 Apr; 17(2):217-22. PubMed ID: 15179033
[TBL] [Abstract][Full Text] [Related]
37. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
38. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.
Liang DC; Chou TB; Chen JS; Shurtleff SA; Rubnitz JE; Downing JR; Pui CH; Shih LY
Leukemia; 1996 Jun; 10(6):991-3. PubMed ID: 8667657
[TBL] [Abstract][Full Text] [Related]
39. The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhood.
Kempski HM; Sturt NT
Leuk Lymphoma; 2000 Dec; 40(1-2):39-47. PubMed ID: 11426627
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter.
Fears S; Gavin M; Zhang DE; Hetherington C; Ben-David Y; Rowley JD; Nucifora G
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1949-54. PubMed ID: 9050885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]